Every time you collect a prescription from your local pharmacy, a complex behind-the-scenes pricing system ensures the NHS can afford to provide that medicine whilst encouraging pharmaceutical companies to keep developing life-saving treatments. A new briefing from the House of Commons Library has revealed exactly how this delicate balancing act works.
For most branded prescription medicines – those still under patent protection – pricing is managed through the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS). This agreement between the Department of Health and Social Care and pharmaceutical companies sets a ceiling on how much NHS spending on branded medicines can grow each year. When actual spending exceeds this cap, participating companies must pay a rebate to the Government, effectively protecting taxpayers from spiralling drug costs.
Generic medicines – off-patent versions of original drugs that are typically much cheaper – operate under a completely different system. Here, market competition amongst multiple manufacturers naturally drives prices down, often making these medicines considerably more affordable for the NHS. However, the Government can step in to regulate prices for specific generic drugs if companies are charging excessively or if the market isn't working properly.
The Department of Health and Social Care oversees these pricing policies, working to ensure the NHS has access to effective treatments whilst managing public spending responsibly. This involves constant negotiation with pharmaceutical companies and regular review of how well the systems are working.
These mechanisms matter because they directly affect what treatments are available through the NHS and how much the health service spends on medicines. The schemes aim to give pharmaceutical companies enough financial certainty to invest in developing new drugs, whilst protecting the NHS budget from unsustainable cost increases. As medical science advances and economic conditions change, these systems continue to evolve to meet new challenges.